Effectiveness of sophrology (a mind-body method) on patients with anxiety

ISRCTN ISRCTN40663142
DOI https://doi.org/10.1186/ISRCTN40663142
Submission date
06/06/2022
Registration date
28/06/2022
Last edited
29/06/2022
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
According to the World Health Organisation (WHO), anxiety and mood disorders are the largest cause of human disability in the world and more than 260 million people suffer from an anxiety disorder. Anxiety and depression have a significant economic impact: it has been estimated that the cost in lost productivity on the global economy is about US$ 1 trillion annually. In line with the proposal of the Committee of Permanent Representatives, the European Social Affairs Council calls for the adoption of a new EU strategic framework on health and safety at work for the period 2021-2027, amongst others, relating to psychosocial risks and stress at work, which are among the most difficult and most urgent problems mentioned in this document.
This study is in line with a previous study which assessed the effectiveness of the structured stress management program "sophrology and wellbeing" (SW) in reducing anxiety and depression symptoms in patients with a moderate or high level of anxiety. The aim of this second study is to investigate if a stress management sophrology training program based on two 1-hour sessions a week for 4 consecutive weeks is as effective at reducing anxiety and depression as the previous program based on three 1-hour sessions a week for 4 consecutive weeks.

Who can participate?
Patients aged between 18 and 70 years with anxiety and depression symptoms

What does the study involve?
Participants are randomly allocated to the sophrology and wellbeing program or a theory-based control program consisting of healthy habits recommendations. Anxiety and depression symptoms are measured before and after the interventions.

What are the possible benefits and risks of participating?
The possible benefits of participation in this study are the reduction of anxiety and depression symptoms.

Where is the study run from?
Autonomous University of Barcelona (Spain)

When is the study starting and how long is it expected to run for?
May 2015 to November 2017

Who is funding the study?
Investigator initiated and funded

Who is the main contact?
Dr Koen van Rangelrooij, koen@sofrocay.com

Contact information

Mr Koen van Rangelrooij
Scientific

Carrer del Pintor Utrillo, 5
Bellaterra, Cerdanyola del Vallès
08193
Spain

Phone +34 (0)625077021
Email koen@sofrocay.com

Study information

Study designProspective controlled randomized study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)GP practice
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a participant information sheet
Scientific titleEffectiveness of Caycedian sophrology in patients with moderate and high anxiety levels: a second prospective randomized controlled study
Study objectivesThe stress management sophrology and wellbeing program based on two 1-hour sessions a week is less effective at reducing anxiety and depression symptomatology than the three 1-hour sessions a week program for 4 consecutive weeks.
Ethics approval(s)Approved 20/10/2015, Ethics Committee: "Investigación Clínica Parc de Salut MAR" (CEIm – Parc de Salut MAR, Dr. Aiguader, 88, 08003, Barcelona, Spain; +34 (0)93 316 06 77; ceic-psmar@imim.es ), ref: 2015/6141/I
Health condition(s) or problem(s) studiedModerate and high anxiety levels
InterventionPatients are randomly assigned into two groups of 35 participants following simple randomization. Following the list of selected patients, every multiple of seven is called by telephone (patient 7,14, 21, etc) and alternately assigned to the intervention group or the control group until the number of 35 participants is reached for each group. The sample size is based on medical and statistical considerations.

The sophrology group receive the structured Sophrologie & wellbeing (SW) intervention for 4 consecutive weeks at a rate of two weekly sessions of 1 hour each (theory and practical). The first half of the program is dedicated to a theoretical part (50%) and the other half to practising sophrology techniques (50%), which consist of training in relaxation techniques, breathing exercises, as well as imaging and mental programming techniques (for the past, present, future and personal values). At the end of each session the group receive a summary of the theoretical part and a digital recording of the practised sophrology technique. They are motivated to train daily and to apply what they learn in everyday life and are instructed to know how to manage stress properly and develop a more serene and positive attitude.

The control group receive the exclusively theory-based Healthy Habit Program (HHP) intervention for 4 weeks, also with two 1-hour sessions per week. The program consists of a theoretical part similar to the SW program, and a more interactive part on promoting healthy habits in the face of stress. This interactive part consists of informative videos and/or specialized lectures on the topics covered in the theoretical part. At the beginning of the intervention, participants are informed of the possibility to continue with the sophrology program once the HHP intervention ends.

The programs are administered in two different classrooms, at the same time and on the same days of the week at the primary health care centre facilities. The team of trainers, four health care professionals and Caycedian sophrologists duly train in the SW intervention and impart the interventions to both groups (sophrology and control).

Statistical analyses are performed using SPSS 27th version (IBM Corp.). Descriptive statistics including mean and standard deviation of the HADS and STAI scores for the sophrology and control group are used to describe the different variables used in this study. Repeated measures for the analysis of variance (ANOVA) are used to compare pre- and post-intervention scores for the sophrology and control group (between-groups and within-group intervention effect). The student (t) test is used to compare the basal scores for both groups and to detect possible initial differences between the two groups. The p-value under 0.05 is considered statistically significant for all data analyses. Pre-post Cohen’s (d) effect sizes (ES) are used to measure the effect size in the sophrology and control groups.
Intervention typeBehavioural
Primary outcome measure1. Anxiety and depression symptoms measured using the Hospital Anxiety Depression Scale (HADS) at baseline and after 4 consecutive weeks
2. State and trait anxiety levels measured using the State-Trait Anxiety Inventory (STAI) at baseline and after 4 consecutive weeks
Secondary outcome measuresThere are no secondary outcome measures
Overall study start date05/05/2015
Completion date30/11/2017

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit70 Years
SexBoth
Target number of participants487
Key inclusion criteria1. Scored ≥8 points on the HAD-Anxiety subscale
2. Older than 18 years and younger than 70 years
3. Expressed a formal wish to take part in the research
4. Not presenting any of the exclusion criteria
5. Read and signed an informed consent document
Key exclusion criteriaPatients were excluded from the study if they:
1. Started, changed or increased any pharmacological therapy during the program
2. Suffered from an acute state of severe mental illness (major depression, bipolar disorder and schizophrenia, etc)
3. Planned to participate in other therapies or similar programs such as yoga, meditation, acupuncture or similar during the study
4. Suffered, during the program, from important stressful life events, which could produce a bias in the assessments of the study
5. Were not able to participate because of linguistic, cultural or physical problems
Date of first enrolment01/06/2017
Date of final enrolment14/06/2017

Locations

Countries of recruitment

  • Spain

Study participating centre

Serraparerra Primary Health Care Centre
Carrer diagonal s/n
Cerdanyola del Valles
08290
Spain

Sponsor information

Autonomous University of Barcelona
University/education

Plaça Cívica
Bellaterra, Cerdanyola del valles
08193
Spain

Phone +34 (0)935811111
Email info@uab.cat
Website https://www.uab.cat
ROR logo "ROR" https://ror.org/052g8jq94

Funders

Funder type

Other

Investigator initiated and funded

No information available

Results and Publications

Intention to publish date30/09/2022
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a peer-reviewed journal
IPD sharing planThe datasets generated and analysed during the current study will be available upon request from Koen van Rangelrooij (koen@sofrocay.com).

Editorial Notes

29/06/2022: Internal review.
27/06/2022: Trial's existence confirmed by the Ethics Committee: "Investigación Clínica Parc de Salut MAR".